AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lepage, G.
Right arrow Articles by Roy, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lepage, G.
Right arrow Articles by Roy, C. C.
Agricola
Right arrow Articles by Lepage, G.
Right arrow Articles by Roy, C. C.

American Journal of Clinical Nutrition, Vol 64, 87-93, Copyright © 1996 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis [published erratum appears in Am J Clin Nutr 1997 Feb;65(2):578]

G Lepage, J Champagne, N Ronco, A Lamarre, I Osberg, RJ Sokol and CC Roy
Gastroenterology and Nutrition Units, Hopital Ste-Justine, Universite de Montreal, Canada.

Evidence of lipid peroxidation previously documented in cystic fibrosis (CF) implies an imbalance between free radical generation and antioxidant defense mechanisms. The aim of the present study was to examine the relation between plasma concentrations of malondialdehyde, a marker of lipid peroxidation, and the exogenous antioxidant line of defense. Malondialdehyde concentrations (90.2 +/- 4.7 nmol/L) in 25 children with CF aged 9.6 +/- 0.8 y were higher (P < 0.001) than concentrations (69.1 +/- 2.6 nmol/L) in 17 children used as control subjects and were not correlated with any marker of disease severity. In contrast with their all-rac-alpha-tocopherol status, which was normal as a result of routine supplementation with a 200-mg dose of all- rac-alpha-tocopheryl acetate/d, beta-carotene was very low. A 2-mo open trial in which 12 children with CF aged 11.5 +/- 0.8 y were given 4.42 mg (8.23 mumol) beta-carotene three times per day led to normalization of the malondialdehyde concentration in all but 1 patient, in conjunction with an increase of plasma beta-carotene from 0.08 +/- 0.03 to 3.99 +/- 0.92 mumol/L. Their plasma concentrations were inversely correlated (r = -0.54, P = 0.006) [corrected] with malondialdehyde when the values measured pre- and posttreatment were pooled. We conclude that beta-carotene deficiency contributes to lipid peroxidation in CF and that supplementation may eventually prove to be a useful adjunct for the management of the disease.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. Schupp, E. Olano-Martin, C. Gerth, B. M Morrissey, C. E Cross, and J. S Werner
Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
L. G. Wood, D. A. Fitzgerald, and M. L. Garg
Hypothesis: Vitamin E Complements Polyunsaturated Fatty Acids in Essential Fatty Acid Deficiency in Cystic Fibrosis
J. Am. Coll. Nutr., August 1, 2003; 22(4): 253 - 257.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F.J. Kelly, C. Dunster, and I. Mudway
Air pollution and the elderly: oxidant/antioxidant issues worth consideration
Eur. Respir. J., May 1, 2003; 21(40_suppl): 70S - 75s.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. T. Mayne
Antioxidant Nutrients and Chronic Disease: Use of Biomarkers of Exposure and Oxidative Stress Status in Epidemiologic Research
J. Nutr., March 1, 2003; 133(3): 933S - 940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. G Wood, D. A Fitzgerald, A. K Lee, and M. L Garg
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
Am. J. Clinical Nutrition, January 1, 2003; 77(1): 150 - 159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. G Wood, D. A Fitzgerald, P. G Gibson, D. M Cooper, and M. L Garg
Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients
Am. J. Clinical Nutrition, April 1, 2002; 75(4): 668 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
L. G. Wood, D. A. Fitzgerald, P. G. Gibson, D. M. Cooper, C. E. Collins, and M. L. Garg
Oxidative Stress in Cystic Fibrosis: Dietary and Metabolic Factors
J. Am. Coll. Nutr., April 1, 2001; 20(2): 157 - 165.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S Renner, R Rath, P Rust, S Lehr, T. Frischer, I Elmadfa, and I Eichler
Effects of {beta}-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis
Thorax, January 1, 2001; 56(1): 48 - 52.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. D. Haegele, C. Gillette, C. O’Neill, P. Wolfe, J. Heimendinger, S. Sedlacek, and H. J. Thompson
Plasma Xanthophyll Carotenoids Correlate Inversely with Indices of Oxidative DNA Damage and Lipid Peroxidation
Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 421 - 425.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The American Society for Nutrition